Divis Laboratories Ltd. | DIVISLAB | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2019
2020
2021
2022
2023
Net Income
Net Income
18,551
18,195
26,660
36,835
23,686
Cash flow Operating Act...
Cash flow Operating Activities
9,54312,15919,46919,11824,597
Investments in PPE
Investments in PPE
-7,331-11,832-9,102-7,132-4,730
Cash flow Investing Act...
Net cash used for Investment Activities
-6,854-835751-21,949-27,076
Dividend Paid
Dividend Paid
3,20010,24105,3097,964
Cash flow Financing Act...
Net cash provided by Financing Activities
-2,459-10,914-349-5,324-7,972
Cash at beginning of period
Cash at beginning of period
-2092143220,30312,148
Cash at end of period
Cash at end of period
2143220,30312,1481,697
Free Cash Flow
Free Cash Flow
2,212
327
10,367
11,986
19,867